Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases. - Davies LC; Biard L; García-Olmo D; Gilkeson G; Gnecchi M; Kurtzberg J; Kogler G; Blanc KL; Lowdell MW; Pers YM; Sun LY; Tarte K; et al. (Cytotherapy, 2025)